Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Share-based Compensation: 2019-2024

Historic Share-based Compensation for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Dec 2024 value amounting to $49.4 million.

  • Maravai Lifesciences Holdings' Share-based Compensation fell 30.61% to $9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.8 million, marking a year-over-year decrease of 23.68%. This contributed to the annual value of $49.4 million for FY2024, which is 42.87% up from last year.
  • Per Maravai Lifesciences Holdings' latest filing, its Share-based Compensation stood at $49.4 million for FY2024, which was up 42.87% from $34.6 million recorded in FY2023.
  • In the past 5 years, Maravai Lifesciences Holdings' Share-based Compensation registered a high of $49.4 million during FY2024, and its lowest value of $10.5 million during FY2021.
  • Moreover, its 3-year median value for Share-based Compensation was $34.6 million (2023), whereas its average is $34.2 million.
  • In the last 5 years, Maravai Lifesciences Holdings' Share-based Compensation skyrocketed by 1,366.89% in 2020 and then crashed by 57.54% in 2021.
  • Over the past 5 years, Maravai Lifesciences Holdings' Share-based Compensation (Yearly) stood at $24.6 million in 2020, then plummeted by 57.54% to $10.5 million in 2021, then soared by 78.52% to $18.7 million in 2022, then soared by 85.26% to $34.6 million in 2023, then soared by 42.87% to $49.4 million in 2024.